MedPath

Iopamidol

Generic Name
Iopamidol
Brand Names
Isovue 200, Isovue 250, Isovue 300, Isovue 370, Isovue-M, Isovue-M 200
Drug Type
Small Molecule
Chemical Formula
C17H22I3N3O8
CAS Number
60166-93-0
Unique Ingredient Identifier
JR13W81H44
Background

Iopamidol is a contrast agent developed by Bracco with nonionic, low-osmolar properties.

Indication

本品用于腰、胸肌颈段脊髓造影，脑血管造影，周围动脉造影剂静脉造影；也用于心血管、冠状动脉、尿路、关节等的造影剂CT增强。

Clinical Trials
Related News

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

Phase 4
Completed
Conditions
Patient Comfort and Safety
Interventions
First Posted Date
2011-06-20
Last Posted Date
2013-12-19
Lead Sponsor
GE Healthcare
Target Recruit Count
304
Registration Number
NCT01376089
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Kidney Damage In Patients With Severe Fall In eGFR

Phase 4
Terminated
Conditions
Coronary Artery Stenosis
Interventions
First Posted Date
2010-06-04
Last Posted Date
2014-03-17
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
15
Registration Number
NCT01136915
Locations
🇨🇦

Institu De Cardiologie De Montreal, Montreal, Quebec, Canada

Kidney Damage in Patients With Moderate Fall in eGFR

Phase 4
Completed
Conditions
Coronary Artery Stenosis
Interventions
First Posted Date
2010-06-04
Last Posted Date
2020-11-04
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
57
Registration Number
NCT01136876
Locations
🇺🇸

UMDNJ - RWJ Medical School, New Brunswick, New Jersey, United States

🇨🇦

Montreal Heart Institute, Montréal, Quebec, Canada

🇺🇸

The Institute for Clinical Research at Holy Name Medical Center, Teaneck, New Jersey, United States

and more 1 locations

Isovue in Peripheral Digital Subtraction Angiography (DSA)

Phase 4
Completed
Conditions
Peripheral Arterial Occlusive Disease
Interventions
First Posted Date
2010-02-25
Last Posted Date
2013-05-30
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
174
Registration Number
NCT01075217
Locations
🇺🇸

Bracco Diagnostics, Princeton, New Jersey, United States

Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients

Phase 4
Terminated
Conditions
Chronic Renal Impairment
Diabetes Mellitus
Interventions
First Posted Date
2008-10-31
Last Posted Date
2012-01-26
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
23
Registration Number
NCT00782639
Locations
🇺🇸

Bracco Diagnostics Inc., Princeton, New Jersey, United States

Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA

Phase 4
Completed
Conditions
Peripheral Arterial Occlusive Disease
Interventions
First Posted Date
2008-08-22
Last Posted Date
2011-05-09
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
33
Registration Number
NCT00740207

Detection of Pulmonary Embolism With CECT

Phase 4
Completed
Conditions
Pulmonary Embolism
First Posted Date
2006-07-13
Last Posted Date
2008-01-07
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
120
Registration Number
NCT00351754
Locations
🇺🇸

Bracco Diagnostics, Inc., Princeton, New Jersey, United States

Patients With Renal Impairment Undergoing CT

Phase 4
Completed
Conditions
Contrast Induced Nephropathy
First Posted Date
2006-02-16
Last Posted Date
2012-02-08
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
150
Registration Number
NCT00292487
Locations
🇺🇸

Bracco Diagnostics, Inc, Princeton, New Jersey, United States

Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)

Phase 4
Completed
Conditions
Kidney Diseases
First Posted Date
2006-02-10
Last Posted Date
2008-01-07
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
350
Registration Number
NCT00289614
Locations
🇺🇸

Bracco Diagnostics, Inc., Princeton, New Jersey, United States

A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography

Phase 4
Completed
Conditions
CIN
First Posted Date
2006-02-09
Last Posted Date
2006-08-18
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
400
Registration Number
NCT00289029
Locations
🇺🇸

Bracco Diagnostics, Inc, Princeton, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy